SPROTT PHYSICAL GOLD TRUST (PHYS) Fundamental Analysis & Valuation

NYSEARCA:PHYS • CA85207H1047

Current stock price

34.985 USD
+0.6 (+1.76%)
Last:

This PHYS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. PHYS Profitability Analysis

1.1 Basic Checks

  • In the past year PHYS was profitable.
  • In the past year PHYS has reported a negative cash flow from operations.
  • The reported net income has been mixed in the past 5 years: PHYS reported negative net income in multiple years.
  • PHYS had a negative operating cash flow in each of the past 5 years.
PHYS Yearly Net Income VS EBIT VS OCF VS FCFPHYS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

Industry RankSector Rank
ROA 26.73%
ROE 26.73%
ROIC 21.12%
ROA(3y)9.9%
ROA(5y)8.21%
ROE(3y)9.91%
ROE(5y)8.21%
ROIC(3y)N/A
ROIC(5y)N/A
PHYS Yearly ROA, ROE, ROICPHYS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20

1.3 Margins

  • In the last couple of years the Profit Margin of PHYS has remained more or less at the same level.
  • In the last couple of years the Operating Margin of PHYS has remained more or less at the same level.
  • In the last couple of years the Gross Margin of PHYS has remained more or less at the same level.
Industry RankSector Rank
OM 98.82%
PM (TTM) 98.82%
GM 99.95%
OM growth 3Y-4.06%
OM growth 5Y0.25%
PM growth 3Y-4.06%
PM growth 5Y0.25%
GM growth 3Y-0.27%
GM growth 5Y0.09%
PHYS Yearly Profit, Operating, Gross MarginsPHYS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

6

2. PHYS Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, PHYS has more shares outstanding
  • The number of shares outstanding for PHYS has been increased compared to 5 years ago.
  • PHYS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PHYS Yearly Shares OutstandingPHYS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M
PHYS Yearly Total Debt VS Total AssetsPHYS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • An Altman-Z score of 31956.61 indicates that PHYS is not in any danger for bankruptcy at the moment.
  • There is no outstanding debt for PHYS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 31956.61
ROIC/WACCN/A
WACCN/A
PHYS Yearly LT Debt VS Equity VS FCFPHYS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

2.3 Liquidity

  • A Current Ratio of 39482.47 indicates that PHYS has no problem at all paying its short term obligations.
  • PHYS has a Quick Ratio of 39482.47. This indicates that PHYS is financially healthy and has no problem in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 39482.47
Quick Ratio 39482.47
PHYS Yearly Current Assets VS Current LiabilitesPHYS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

5

3. PHYS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 141.03% over the past year.
  • The Earnings Per Share has been growing by 18.47% on average over the past years. This is quite good.
  • The Revenue has grown by 155.11% in the past year. This is a very strong growth!
  • The Revenue has been growing by 36.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)141.03%
EPS 3YN/A
EPS 5Y18.47%
EPS Q2Q%83.56%
Revenue 1Y (TTM)155.11%
Revenue growth 3YN/A
Revenue growth 5Y36.5%
Sales Q2Q%112.03%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
PHYS Yearly Revenue VS EstimatesPHYS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2

4. PHYS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 4.65, the valuation of PHYS can be described as very cheap.
  • PHYS's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.54.
Industry RankSector Rank
PE 4.65
Fwd PE N/A
PHYS Price Earnings VS Forward Price EarningsPHYS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
PHYS Per share dataPHYS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20 25

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.25
EPS Next 2YN/A
EPS Next 3YN/A

0

5. PHYS Dividend Analysis

5.1 Amount

  • No dividends for PHYS!.
Industry RankSector Rank
Dividend Yield 0%

PHYS Fundamentals: All Metrics, Ratios and Statistics

SPROTT PHYSICAL GOLD TRUST

NYSEARCA:PHYS (4/30/2026, 1:08:49 PM)

34.985

+0.6 (+1.76%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Industry StrengthN/A
Industry GrowthN/A
Earnings (Last)03-18
Earnings (Next)05-13
Inst Owners30.08%
Inst Owner Change0.64%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap16.42B
Revenue(TTM)3.24B
Net Income(TTM)3.20B
Analysts0
Price TargetN/A
Short Float %0.17%
Short Ratio0.15
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.65
Fwd PE N/A
P/S 5.07
P/FCF N/A
P/OCF N/A
P/B 1.37
P/tB 1.37
EV/EBITDA N/A
EPS(TTM)7.52
EY21.49%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS6.89
BVpS25.49
TBVpS25.49
PEG (NY)N/A
PEG (5Y)0.25
Graham Number65.6697 (87.71%)
Profitability
Industry RankSector Rank
ROA 26.73%
ROE 26.73%
ROCE 26.73%
ROIC 21.12%
ROICexc N/A
ROICexgc N/A
OM 98.82%
PM (TTM) 98.82%
GM 99.95%
FCFM N/A
ROA(3y)9.9%
ROA(5y)8.21%
ROE(3y)9.91%
ROE(5y)8.21%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-4.06%
OM growth 5Y0.25%
PM growth 3Y-4.06%
PM growth 5Y0.25%
GM growth 3Y-0.27%
GM growth 5Y0.09%
F-ScoreN/A
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 39482.47
Quick Ratio 39482.47
Altman-Z 31956.61
F-ScoreN/A
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)141.03%
EPS 3YN/A
EPS 5Y18.47%
EPS Q2Q%83.56%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)155.11%
Revenue growth 3YN/A
Revenue growth 5Y36.5%
Sales Q2Q%112.03%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y157.53%
EBIT growth 3YN/A
EBIT growth 5Y36.84%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-51.84%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.84%
OCF growth 3YN/A
OCF growth 5YN/A

SPROTT PHYSICAL GOLD TRUST / PHYS Fundamental Analysis FAQ

What is the ChartMill fundamental rating of SPROTT PHYSICAL GOLD TRUST (PHYS) stock?

ChartMill assigns a fundamental rating of 3 / 10 to PHYS.


What is the valuation status of SPROTT PHYSICAL GOLD TRUST (PHYS) stock?

ChartMill assigns a valuation rating of 2 / 10 to SPROTT PHYSICAL GOLD TRUST (PHYS). This can be considered as Overvalued.


How profitable is SPROTT PHYSICAL GOLD TRUST (PHYS) stock?

SPROTT PHYSICAL GOLD TRUST (PHYS) has a profitability rating of 1 / 10.


What are the PE and PB ratios of SPROTT PHYSICAL GOLD TRUST (PHYS) stock?

The Price/Earnings (PE) ratio for SPROTT PHYSICAL GOLD TRUST (PHYS) is 4.65 and the Price/Book (PB) ratio is 1.37.


Can you provide the financial health for PHYS stock?

The financial health rating of SPROTT PHYSICAL GOLD TRUST (PHYS) is 6 / 10.